Melanoma (Excluding Uveal Melanoma)

Oncology·MeSH: Melanoma

Prevalence

75.0 / 100K

Incidence

23.0 / 100K/yr

3 drugs in development·1 company·1 clinical trial

Drug Pipeline by Phase

Compare drugs

Frequently asked questions

How many drugs are in development for Melanoma (Excluding Uveal Melanoma)?

BioSniper tracks 3 drugs in development for Melanoma (Excluding Uveal Melanoma) across 1 company.

How many clinical trials target Melanoma (Excluding Uveal Melanoma)?

There are 1 clinical trial targeting Melanoma (Excluding Uveal Melanoma) tracked by BioSniper.

What is the prevalence of Melanoma (Excluding Uveal Melanoma)?

The estimated prevalence of Melanoma (Excluding Uveal Melanoma) is approximately 75.0 per 100,000 population.

Deep-dive into Melanoma (Excluding Uveal Melanoma)

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Melanoma (Excluding Uveal Melanoma) — Drugs in Development & Clinical Trials | BioSniper